|
|
 Previous Article | Table of Contents | Next Article 
Transient Thrombocytopenia Produced by Administration of Macrophage
Colony-Stimulating Factor: Investigations of the Mechanism
Georgiann R. Baker and
Jack Levin
From the Departments of Laboratory Medicine and Medicine, University
of California School of Medicine and the Veterans Affairs Medical
Center, San Francisco, CA.
Administration of macrophage colony-stimulating factor (M-CSF) to
mice (2 to 8 mg/kg/d × 5d) produced dose-dependent thrombocytopenia, which reached its nadir on days 4 to 5, followed by rapid recovery. Surprisingly, when administration of M-CSF was prolonged, the thrombocytopenia completely resolved, despite continued treatment. Splenectomy did not prevent the thrombocytopenia. Readministration of
M-CSF after various intervals continued to produce the thrombocytopenic effect, even after 35 days. Measurements of Meg-CFC and
megakaryocyte ploidy during the periods of M-CSF treatment and recovery
of normal platelet levels showed no evidence of bone marrow
suppression. Platelet survival was markedly decreased after 5 days of
M-CSF (at the platelet count nadir) and after 9 days of continued M-CSF treatment, when the platelet count had returned to normal. Platelets from M-CSF-treated donors demonstrated normal survival when transfused into normal recipients. We concluded that thrombocytopenia produced by
M-CSF was not due to suppression of thrombopoiesis, but to increased
activity of the monocyte/macrophage system, which caused shortened
platelet survival, and that subsequently, increased platelet production
compensated for ongoing platelet destruction and resulted in normal
platelet levels.
Blood, Vol. 91 No. 1 (January 1), 1998:
pp. 89-99
© 1998 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
T. G. DeLoughery
Thrombocytopenia in Critical Care Patients
J Intensive Care Med,
November 1, 2002;
17(6):
267 - 282.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T. Yamao, T. Noguchi, O. Takeuchi, U. Nishiyama, H. Morita, T. Hagiwara, H. Akahori, T. Kato, K. Inagaki, H. Okazawa, et al.
Negative Regulation of Platelet Clearance and of the Macrophage Phagocytic Response by the Transmembrane Glycoprotein SHPS-1
J. Biol. Chem.,
October 11, 2002;
277(42):
39833 - 39839.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Levin, L. Cocault, C. Demerens, C. Challier, M. Pauchard, J. Caen, and M. Souyri
Thrombocytopenic c-mpl{-}/{-} mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response
Blood,
August 15, 2001;
98(4):
1019 - 1027.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Oren, N. Duman, H. Abacioglu, H. Ozkan, and G. Irken
Association Between Serum Macrophage Colony-Stimulating Factor Levels and Monocyte and Thrombocyte Counts in Healthy, Hypoxic, and Septic Term Neonates
Pediatrics,
August 1, 2001;
108(2):
329 - 332.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. D. Car and V. M. Eng
Special Considerations in the Evaluation of the Hematology and Hemostasis of Mutant Mice
Vet. Pathol.,
January 1, 2001;
38(1):
20 - 30.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Loo and Y. Beguin
The Effect of Recombinant Human Erythropoietin on Platelet Counts Is Strongly Modulated by the Adequacy of Iron Supply
Blood,
May 15, 1999;
93(10):
3286 - 3293.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
